SEC Form 4 · accession 0001225208-19-000698
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry L Wood
Officer — CVP, THV Replacement
Period of report
Jan 7, 2019
Accepted (ET)
Jan 7, 2019 · 5:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 7, 2019 | M | 6,716 | $41.94 | A | 122,366 | D | |
| Common Stock | Jan 7, 2019 | S | 6,716 | $148.15 | D | 115,650 | D | |
| Common StockF2 | holding | — | — | — | 165 | I | 401(k) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Acquire) | $41.94 | Jan 7, 2019 | M | 6,716 | D | May 8, 2015 | May 7, 2021 | Common Stock | 6,716 | 73,884 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2018.
- F2Shares represented on the most recent statement of the 401(k) Plan Administrator.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.